Dr. Casola is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
301 University Blvd
Galveston, TX 77555Phone+1 409-772-2798Fax+1 409-772-0885
Summary
- Dr. Antonella Casola is a Pediatric Infectious Disease specialist located in Galveston, TX. She completed her fellowship in Pediatric Infectious Diseases at the University of Texas Medical Branch Hospitals. She currently serves as a Professor of Pediatrics and Director of the Pediatric Infectious Diseases Division at UTMB. Dr. Casola has contributed to multiple publications, including recent works focused on RSV and SARS-CoV-2 co-infection and the role of hypoxia-inducible factors and NRF2 in viral infections. Her research emphasizes viral replication and responses in airway epithelial cells.
Education & Training
- University of Texas Medical Branch HospitalsFellowship, Pediatric Infectious Diseases, 2002 - 2005
- University of Naples Faculty of MedicineClass of 1989
Certifications & Licensure
- TX State Medical License 2004 - 2025
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Hypoxia-inducible-factors differentially contribute to clinical disease and viral replication during RSV infection.Dorothea R Morris, Yue Qu, Aline Haas de Mello, Yava L Jones-Hall, Tianshuang Liu
Biorxiv. 2024-12-16 - 16 citationsSARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection.Yue Qu, Aline Haas de Mello, Dorothea R Morris, Yava L Jones-Hall, Teodora Ivanciuc
Microbiology Spectrum. 2023-06-15 - 2 citationsThe impact of RSV/SARS-CoV-2 co-infection on clinical disease and viral replication: insights from a BALB/c mouse model.Dorothea R Morris, Yue Qu, Kerrie S Thomason, Aline Haas de Mello, Richard Preble
Biorxiv. 2023-05-24
Press Mentions
- A Virus with No Vaccine, Treatment Is in the UTMB Research CrosshairsSeptember 27th, 2018
- Hydrogen Sulfide May Be a Promising Tool in Fighting Highly Infectious VirusesJanuary 20th, 2017
- Augmenting a Gas Naturally in Our Bodies Fights RSV InfectionApril 27th, 2015
Grant Support
- PIWIL4 and piRNAs in RSV InfectionUNIVERSITY OF TEXAS MED BR GALVESTON2023–2025
- Role of Hypoxia-Inducible Factors (HIFs) in Respiratory Syncytial Virus InfectionUNIVERSITY OF TEXAS MED BR GALVESTON2023–2025
- Hydrogen Sulfide and NRF2 Cross-talk in Viral InfectionsUNIVERSITY OF TEXAS MED BR GALVESTON2017–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: